The Swoop and Patient Advocacy and Privacy Advisory Board

The ability of data-driven technology companies to predict and shape patient outcomes creates both an opportunity and a responsibility: the responsibility to uphold and protect patient and consumer privacy. The lack of regulatory and guidelines in this emerging area complicates matters, as questions such as “What is a positive patient outcome, and who sets the standard?”, “What data is acceptable to use in order to make predictions, and who decides?” exist in a grey area with no clearly defined answers.

It is in order to lead the industry away from that ambiguity that we formed the Swoop and Patient Advocacy and Privacy Advisory Board. The Board will allow Swoop and to continue to be at the forefront of using the constantly-improving power of AI and digital messaging for direct patient benefits while protecting consumer rights and lowering healthcare costs.

The Swoop and Patient Advocacy and Privacy Advisory Board Members

Patricia Bailin
Patricia BailinHead of Privacy and Data Ethics, Datavant
Based in the Bay Area, Patricia is a leading expert in the ever-more-important realm of data privacy. Before joining Datavant, she was the Privacy Officer for LiveRamp and the Director of Privacy for Product and Engineering at Acxiom. Additionally, she served as a Westin Fellow at the International Association of Privacy Professionals (IAPP) Westin Research Center.
Jennifer Beachell
Jennifer BeachellBiopharma Industry Commercial Strategist
Jennifer is an experienced commercial strategist in the rare disease and oncology biopharma industry. She has worked as the President of US Commercial at Aegerion Pharmaceuticals, VP of Marketing and Market Access at Welldoc and Head of Marketing at Human Genome Sciences, as well as operating her own biopharma consultancy.
Jodie Sherman Gillon
Jodie Sherman GillonGlobal Medical Lead, Patient Engagement Rare Diseases, Pfizer
With an impressive career focused on medical and patient affairs, Jodie has spent two decades helping pharmaceutical companies develop cutting-edge programs for patient and physician engagement. A prolific speaker, her passion is leveraging big data to tackle industry-wide challenges such as improving diagnosis rates for challenging conditions.